Why did this thing fail in phase 3 again? From my memory, the FDA wanted clarification on something so it wasnt really a failure. I also recall that the data was very positive. Does anyone recall what really happened and post it. Someone must have a link somewhere.. Thanks..
It never failed in phase III MVAX. On the second round with the newer frozen version and special lab cleanup, etc. the company ran short on funding and put the Phase III MVAX study on hold. Dr. Berd went to CTCA, became chair of their board and worked out the agreement to work on the OVAX trials. Their completion is what has been moved up and I believe it was due to needing more test subjects (thus the opening of more treatment centers being added). Money for continuation of the MVAX trials is probably still dependent on the results of the OVAX study and will likely be moved into the future farther unless some of the successes can be shared with potential investors. Thsy are not really secret since some of the participants have shared results on CTCA website.